UMB Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $323K | Buy |
1,762
+163
| +10% | +$30K | ﹤0.01% | 577 |
|
|
2025
Q4 | $281K | Buy |
1,599
+163
| +11% | +$26.6K | ﹤0.01% | 593 |
|
|
2025
Q3 | $201K | Buy |
1,436
+407
| +40% | +$55K | ﹤0.01% | 612 |
|
|
2025
Q2 | $129K | Buy |
1,029
+557
| +118% | +$69.4K | ﹤0.01% | 732 |
|
|
2025
Q1 | $64.6K | Buy |
472
+221
| +88% | +$31.6K | ﹤0.01% | 947 |
|
|
2024
Q4 | $38.4K | Sell |
251
-174
| -41% | -$29.3K | ﹤0.01% | 1019 |
|
|
2024
Q3 | $82.4K | Buy |
425
+178
| +72% | +$37.2K | ﹤0.01% | 740 |
|
|
2024
Q2 | $57.3K | Buy |
247
+144
| +140% | +$31.3K | ﹤0.01% | 799 |
|
|
2024
Q1 | $22.2K | Sell |
103
-571
| -85% | -$134K | ﹤0.01% | 1034 |
|
|
2023
Q4 | $174K | Hold |
674
| – | – | ﹤0.01% | 609 |
|
|
2023
Q3 | $173K | Sell |
674
-23
| -3% | -$6.15K | ﹤0.01% | 594 |
|
|
2023
Q2 | $199K | Hold |
697
| – | – | ﹤0.01% | 580 |
|
|
2023
Q1 | $194K | Sell |
697
-10
| -1% | -$2.77K | ﹤0.01% | 575 |
|
|
2022
Q4 | $196K | Buy |
707
+4
| +0.6% | +$1.13K | ﹤0.01% | 589 |
|
|
2022
Q3 | $187K | Hold |
703
| – | – | ﹤0.01% | 615 |
|
|
2022
Q2 | $143K | Buy |
703
+4
| +0.6% | +$818 | ﹤0.01% | 680 |
|
|
2022
Q1 | $147K | Sell |
699
-105
| -13% | -$22.8K | ﹤0.01% | 711 |
|
|
2021
Q4 | $193K | Buy |
+804
| New | +$207K | ﹤0.01% | 671 |
|
|
2017
Q2 | – | Sell |
-897
| Closed | -$245K | – | 319 |
|
|
2017
Q1 | $245K | Hold |
897
| – | – | 0.01% | 308 |
|
|
2016
Q4 | $254K | Sell |
897
-140
| -14% | -$41.5K | 0.01% | 299 |
|
|
2016
Q3 | $325K | Sell |
1,037
-91
| -8% | -$27K | 0.01% | 282 |
|
|
2016
Q2 | $273K | Sell |
1,128
-6,609
| -85% | -$1.74M | 0.01% | 297 |
|
|
2016
Q1 | $2.01M | Buy |
7,737
+1,075
| +16% | +$284K | 0.09% | 145 |
|
|
2015
Q4 | $2.04M | Buy |
6,662
+355
| +6% | +$102K | 0.09% | 158 |
|
|
2015
Q3 | $1.84M | Sell |
6,307
-807
| -11% | -$266K | 0.11% | 132 |
|
|
2015
Q2 | $2.87K | Buy |
7,114
+274
| +4% | +$110K | 0.13% | 120 |
|
|
2015
Q1 | $2.89K | Sell |
6,840
-470
| -6% | -$185K | 0.13% | 122 |
|
|
2014
Q4 | $2.48M | Sell |
7,310
-6,140
| -46% | -$1.99M | 0.11% | 127 |
|
|
2014
Q3 | $4.45K | Buy |
13,450
+7,053
| +110% | +$2.33M | 0.22% | 98 |
|
|
2014
Q2 | $2.02M | Sell |
6,397
-81
| -1% | -$24.4K | 0.1% | 138 |
|
|
2014
Q1 | $1.98M | Buy |
+6,478
| New | +$2.06M | 0.11% | 128 |
|
Other funds holding BIIB
VCM
VPM
UMB Bank's BIIB Position: Q1 2026 in Review
UMB Bank increased its Biogen (BIIB) stake by 10% in Q1 2026, buying an estimated $30K and bringing the position to 1,762 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #577.
UMB Bank first reported a position in BIIB in Q1 2014 and has held it in 31 quarters since. The position peaked at $2.48M in Q4 2014. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- UMB Bank held 1,762 shares of Biogen worth $323K as of Q1 2026.
- UMB Bank bought 163 Biogen shares in Q1 2026, an estimated $30K.
- Biogen made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #577 holding.
- UMB Bank first reported a position in Biogen in Q1 2014 and has held it in 31 quarters since.
- UMB Bank's Biogen position peaked at $2.48M in Q4 2014.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.